Literature DB >> 475695

Keratoacanthoma in a sub-tropical climate.

J J Sullivan, G A Colditz.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 475695     DOI: 10.1111/j.1440-0960.1979.tb00122.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


× No keyword cloud information.
  6 in total

1.  Keratoacanthomas associated with sorafenib therapy.

Authors:  Heidi H Kong; Edward W Cowen; Nilofer S Azad; William Dahut; Martin Gutierrez; Maria L Turner
Journal:  J Am Acad Dermatol       Date:  2007-01       Impact factor: 11.527

Review 2.  Cutaneous lesions of the nose.

Authors:  Michael Sand; Daniel Sand; Christina Thrandorf; Volker Paech; Peter Altmeyer; Falk G Bechara
Journal:  Head Face Med       Date:  2010-06-04       Impact factor: 2.151

3.  Skin tumors in aging Long Evans rats.

Authors:  Adeleh Esfandiari; Theresa Loya; Jeffrey L Lee
Journal:  J Natl Med Assoc       Date:  2002-06       Impact factor: 1.798

4.  Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Queensland, Australia.

Authors:  Magdalena Claeson; Nirmala Pandeya; Jean-Claude Dusingize; Bridie S Thompson; Adele C Green; Rachel E Neale; Catherine M Olsen; David C Whiteman
Journal:  JAMA Dermatol       Date:  2020-12-01       Impact factor: 10.282

5.  Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization.

Authors:  Ole Petter F Clausen; Hans Christian D Aass; Marzieh Beigi; Karin J Purdie; Charlotte M Proby; Victoria L Brown; Morten Mattingsdal; Francesca Micci; Steen Kølvraa; Lars Bolund; Paula M Deangelis
Journal:  J Invest Dermatol       Date:  2006-05-25       Impact factor: 8.551

6.  Patient and Tumour Characteristics of Keratoacanthoma in a Large, Community-based Cohort Study from Queensland, Australia.

Authors:  Agnes Kolmodin; Nirmala P Pandeya; Catherine M Olsen; Jean Claude Dusingize; David C Whiteman; Magdalena Claeson
Journal:  Acta Derm Venereol       Date:  2021-06-02       Impact factor: 3.875

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.